Literature DB >> 24166517

Reply to U.R. Mansmann et al and M.-W. An et al.

Laurent Claret1, René Bruno.   

Abstract

Mesh：

Year:  2013        PMID： 24166517     DOI： 10.1200/JCO.2013.52.5733

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin.

Authors:  J G C van Hasselt; A Gupta; Z Hussein; J H Beijnen; J H M Schellens; A D R Huitema
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-06-30

2.  Model-Based Estimates of Tumor Growth Inhibition Metrics Are Time-Independent: A Reply to Mistry.

Authors:  L Claret; K Han; R Bruno
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.